期刊文献+

Current trends in the development and application of molecular technologies for cancer epigenetics 被引量:3

Current trends in the development and application of molecular technologies for cancer epigenetics
下载PDF
导出
摘要 Current progress in epigenetic research supports the view that diet and dietary components are important in cancer etiology by enhancing or inhibiting carcinogenesis.Since diet and dietary factors may significantly contribute to the causation and progression of many cancers,it is important to find the molecular mechanisms of action of such dietary factors for cancer prevention and treatment.Recently,the role of epigenetic mechanisms in the cancer development and progression has attracted more attention as additional evidence along with traditional DNA sequence based mechanisms such as mutations and structural re-arrangements.Such an increasing interest in cancer epigenetics has also accelerated the development and application of molecular assays and tools for DNA methylation detection and histone modification enrichment analysis.In this paper,key assays and methods for epigenetic research are reviewed and discussed in terms of their utility and usability.In addition,more advanced methods for genome-wide analysis are introduced as part of upcoming research trends and directions. Current progress in epigenetic research supports the view that diet and dietary components are important in cancer etiology by enhancing or inhibiting carcinogenesis. Since diet and dietary factors may significantly contribute to the causation and progression of many cancers, it is important to find the molecular mechanisms of action of such dietary factors for cancer prevention and treatment. Recently, the role of epigenetic mechanisms in the cancer development and progression has attracted more attention as additional evidence along with traditional DNA sequence based mechanisms such as mutations and structural re-arrangements. Such an increasing interest in cancer epigenetics has also accelerated the development and application of molecular assays and tools for DNA methylation detection and histone modification enrichment analysis. In this paper, key assays and methods for epigenetic research are reviewed and discussed in terms of their utility and usability. In addition, more advanced methods for genome-wide analysis are introduced as part of upcoming research trends and directions.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第7期1030-1039,共10页 世界胃肠病学杂志(英文版)
关键词 Cancer EPIGENETIC Technology BUTYRATE HISTONE modifications DIET METHYL SOURCES Cancer Epigenetic Technology Butyrate Histone modifications Diet Methyl sources
  • 相关文献

参考文献98

  • 1JingYuanFANG YingXuanCHEN JuanLU RongLU LiYANG HongYinZHU WeiQiGU LunGenLU.Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116[J].Cell Research,2004,14(3):217-226. 被引量:46
  • 2Philippe Collas.The Current State of Chromatin Immunoprecipitation[J]. Molecular Biotechnology . 2010 (1)
  • 3Trosko,J. E.,Upham,B. L.The emperor wears no clothes in the field of carcinogen risk assessment: Ignored concepts in cancer risk assessment. Mutagenesis . 2005
  • 4Hake SB,Xiao A,Allis CD.Linking the epigenetic ’’language’’ of covalent histone modifications to cancer. British Journal of Cancer . 2004
  • 5Esteller M.Epigenetics provides a new generation of oncogenes and tumor supp-ressor genes. British Journal of Cancer . 2006
  • 6Ghoshal AK,Farber E.The induction of liver cancer by di- etary deficiency of choline and methionine without added carcinogens. Carcinogenesis . 1984
  • 7Jackson,V.,Shires,A.,Chalkley,R.,Granner,D. K.Studies on highly metabolically active acetylation and phosphorylation of histone. Journal of Biological Chemistry . 1975
  • 8Poirier LA.Methyl group deficiency in hepatocarcinogenesis. Drug Metabolism Reviews . 1994
  • 9Pogribny IP,Shpyleva SI,Muskhelishvili L,Bagnyukova TV,James SJ,Beland FA.Role of DNA damage and altera- tions in cytosine DNA methylation in rat liver carcinogen- esis induced by a methyl-deficient diet. Mutation Research . 2009
  • 10Christman JK,Sheikhnejad G,Dizik M,Abileah S.Wainfan E: Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis . 1993

二级参考文献55

  • 1[1]Russo P, Malacarne D, Falugi C, Trombino S, O'Connor PM.RPR-115135, a farnesyltransferase inhibitor, increase 5-FUcytotoxicity in ten human colon cancer cell lines: Role of p53.Int J Cancer 2002; 100:266-75.
  • 2[2]Mori H, Niwa K, Zheng Q, et al. Cell proliferation in cancer prevention; effects of preventive agents on estrogen-related endometrial carcinogenesis model and on an in vitro model in human colorectal cells. Mutat Res 2001; 480-481:201-7.
  • 3[3]Ding X, Flatt PR, Permert J, Adrian TE. Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin. Gastroenterology 1998; 114:130-8.
  • 4[4]Rylova SN, Amalifitano A, Persaud-Sawin DA, et al. The CLN3gene is a novel molecular target for cancer drug discovery. Cancer Res 2002; 62:80l-8.
  • 5[5]Gao Z, Fields JZ, Boman BM. Tumor-specific expression of anti-mdrl ribozyme selectively restores chemosensitivity in multidrug-resistant colon- adenocarcinoma cells. Int J Cancer 1999;82:346-52.
  • 6[6]Shiraki K, Tsuji N, Shioda T, Isselbacher KJ, Takahashi H. Expression of Fas ligand in liver metastases of human colonic adenocarcinoma. Proc Natl Acad Sci USA 1997; 94:6420-5
  • 7[7]Mateyak MK, Obaya AJ, Sedivy JM. C-myc regulates cyclin DCdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol Cell Biol 1999; 19:4672-83
  • 8[8]Nagai MA, Habr-Gama A, Oshima CT, Brentani MM. Association of genetic alterations of c-myc, c-fos, and c-Ha-ras protooncogenes in colorectal tumors. Frquency and clinical significance.Dis Colon Rectum 1992; 35:444-51.
  • 9[9]van Es JH, Giles RH, Clevers HC. The many faces of the tumor suppressor gene APC. Exp Cell Res 2001; 264:126-34
  • 10[10]O'Leary JJ, Landers RJ, Crowley M, et al. Alterations in exon 1of c-myc and expression of p62 c-myc in cervical squamous cell carcinoma. J Clin Pathol 1997; 50:896-903.

共引文献45

同被引文献13

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部